Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
107.97
+1.79 (+1.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
3 No-Brainer Stocks to Buy Right Now for Less than $100
October 23, 2023
You can start with a small investment and win big over time.
Via
The Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?
October 22, 2023
Venture beyond the headlines on a journey among 2023's least celebrated S&P 500 stocks. A roadmap to informed investment decisions awaits.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Moderna Stock Is Sinking This Week
October 19, 2023
Investors appear to believe that bad news for Pfizer could mean bad news for Moderna.
Via
The Motley Fool
3 Stocks That Are Dead in the Water
October 19, 2023
These three stocks to avoid once had promising futures, but their best moments are now behind them.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
Via
Benzinga
Moderna to Host Second Digital Investor Event on November 8th, 2023
October 19, 2023
Via
ACCESSWIRE
Check Out What Whales Are Doing With MRNA
October 16, 2023
Via
Benzinga
Moderna Unusual Options Activity For October 12
October 12, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
October 12, 2023
Both companies are known innovators.
Via
The Motley Fool
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
October 19, 2023
The transition to the commercial market is planned for 2024 and could bolster sales.
Via
Investor's Business Daily
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
October 19, 2023
The coronavirus vaccine leaders recently made different decisions.
Via
The Motley Fool
Exposures
COVID-19
China's Quarterly GDP Grew More Than Expected
October 18, 2023
China's gross domestic product GDP grew by 4.9% in the last quarter, exceeding expectations of 4.4% growth. However, the figure was weaker than the 6.3% growth seen in the previous quarter.
Via
Talk Markets
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
October 17, 2023
U.S. stocks exhibited a mixed performance as the trading day drew to a close, with the Nasdaq Composite taking a dip of around 30 points.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Moderna Stock?
October 17, 2023
Moderna Inc (NASDAQ: MRNA) shares are continuing to trade lower Tuesday following Pfizer Inc's (NYSE: PFE) warning about
Via
Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
Coronavirus vaccine sales could represent recurrent annual revenue for Novavax and rivals.
Via
The Motley Fool
Exposures
COVID-19
Healthcare Portfolio Focus Stocks
October 16, 2023
The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields.
Via
Talk Markets
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
October 16, 2023
Pfizer cut about $9 billion from its sales expectations for Covid products this year.
Via
Investor's Business Daily
Exposures
COVID-19
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.
Via
Benzinga
Exposures
COVID-19
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
October 16, 2023
Some big 2023 winners are shorted heavily, including two AI plays.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 16, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Is Novavax Stock a Buy Now?
October 16, 2023
Is this company just a pandemic stock?
Via
The Motley Fool
Don’t Hold On: 7 Stocks to Sell Before 2024
October 15, 2023
Consider it best to jettison these seven stocks to sell from your portfolio, between now and the end of 2023.
Via
InvestorPlace
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
October 13, 2023
One of these players could win in AI -- and in the healthcare market, in general.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
October 12, 2023
Via
ACCESSWIRE
3 Stocks That Are Down Big, But Are Due to Fall Much Further
October 12, 2023
While the search for falling stocks is an easy one, these are the ones that might not get up from the mat.
Via
InvestorPlace
The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?
October 11, 2023
Vaccine revenue may have slipped but could still represent billions of dollars for these companies.
Via
The Motley Fool
Exposures
COVID-19
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
3 Shaky Stocks to Sell in October Before It’s Too Late
October 09, 2023
Investors who are concerned about the direction of the market moving forward should sell these three vulnerable stocks now.
Via
InvestorPlace
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
October 09, 2023
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in
Via
Benzinga
Exposures
COVID-19
Product Safety
Privatized Vaccine Distribution Sparks Confusion, Payment Challenges
October 09, 2023
As the rollout of the updated COVID-19 vaccine progresses, some individuals have been surprised by requests for upfront payments ranging from $150 to $200.
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.